Le Lézard
Classified in: Business
Subject: DIV

ZIONS BANCORPORATION'S BOARD DECLARES DIVIDENDS ON COMMON AND PREFERRED STOCK


SALT LAKE CITY, April 26, 2024 /PRNewswire/ -- Zions Bancorporation, N.A. (NASDAQ: ZION) announced today that its board of directors ("board") declared a regular quarterly dividend of $0.41 per common share, payable May 23, 2024, to shareholders of record at the close of business on May 16, 2024.

Additionally, the board declared regular quarterly cash dividends on the company's various perpetual preferred shares, as detailed below.

The cash dividend on the following series are payable June 15, 2024, to shareholders of record on June 1, 2024:

Zions Bancorporation, N.A. is one of the nation's premier financial services companies with 2023 net revenue of $3.1 billion and approximately $87 billion of total assets. Founded in 1873, Zions operates under local management teams and distinct brands in 11 western states: Arizona, California, Colorado, Idaho, Nevada, New Mexico, Oregon, Texas, Utah, Washington, and Wyoming. The Bank is a consistent recipient of national and state-wide customer survey awards in small and middle-market banking, as well as a leader in public finance advisory services and Small Business Administration lending. In addition, Zions is included in the S&P 400 and NASDAQ Financial 100 indices. Investor information and links to local banking brands can be accessed at zionsbancorporation.com.

SOURCE Zions Bancorporation


These press releases may also interest you

at 03:00
When it comes to the number of resident millionaires with liquid investable wealth of USD 1 million or more, the US leads the pack, with 11 cities in the Top 50, including New York City, which holds firmly onto 1st place in the 2024 World's...

at 03:00
VONQ, a global HR Tech player and leader in AI-powered...

at 03:00
IRIS Software Group (IRIS), a leading global software provider of accounting, edtech, HR and payroll solutions, today announced the appointment of Gus Malezis as non-executive Chairman. This move aligns with IRIS' strategic goals for expansion and...

at 03:00
To drive new growth across its existing and future fund products, Amwal Capital Partners, an independent alternative investment firm based in Dubai, announces it has enhanced its portfolio and trade order management operations with the implementation...

at 03:00
Today, Cell Impact has entered into a main agreement with Japanese company F.C.C., which governs the continued collaboration between the two companies to secure business primarily in Japan, India, and China....

at 03:00
Sciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation, a South Korean commercial stage pharmaceutical company (KOSDAQ: 195940), today announced a...



News published on and distributed by: